Published in Proc Natl Acad Sci U S A on December 19, 2000
Putting tumours in context. Nat Rev Cancer (2001) 12.37
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet (2005) 4.70
Tumors as organs: complex tissues that interface with the entire organism. Dev Cell (2010) 3.98
Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res (2007) 3.64
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain (2010) 3.53
Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A (2011) 3.45
Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev (2001) 3.39
Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A (2008) 3.27
Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation (2010) 2.53
Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol (2003) 2.37
Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A (2001) 2.36
Molecular determinants of ovarian cancer plasticity. Am J Pathol (2001) 2.32
Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res (2003) 2.12
Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis (2003) 1.89
Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol (2007) 1.89
Imaging angiogenesis and the microenvironment. APMIS (2008) 1.77
Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis (2004) 1.62
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma. Hepatology (2015) 1.42
Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am J Pathol (2002) 1.40
Tumor endothelial cells. Cold Spring Harb Perspect Med (2012) 1.39
Intravital microscopy: new insights into metastasis of tumors. J Cell Sci (2011) 1.36
"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One (2014) 1.34
Imaging hallmarks of cancer in living mice. Nat Rev Cancer (2014) 1.32
TRAIL-coated leukocytes that kill cancer cells in the circulation. Proc Natl Acad Sci U S A (2014) 1.31
Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors. Cancer Res (2010) 1.24
Breast tumour angiogenesis. Breast Cancer Res (2007) 1.22
Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells. Anal Chem (2009) 1.20
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun (2007) 1.20
Lymphatic vessels as targets of tumor therapy? J Exp Med (2001) 1.17
Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation. J Biol Chem (2012) 1.16
Cognitive deficits and delayed neuronal loss in a mouse model of multiple microinfarcts. J Neurosci (2012) 1.15
Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse. Ophthalmic Res (2006) 1.14
Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS One (2008) 1.14
Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J Neurosci (2012) 1.10
Targeting the tumor microenvironment: focus on angiogenesis. J Oncol (2011) 1.09
The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts. J Cutan Pathol (2010) 1.09
Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest Ophthalmol Vis Sci (2005) 1.08
Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis. J Cell Mol Med (2007) 1.07
Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells. PLoS One (2013) 1.05
Tumor angiogenesis: insights and innovations. J Oncol (2010) 1.04
Targeting neovascular pericytes in neurofibromatosis type 1. Angiogenesis (2005) 1.04
Antiangiogenic gene therapy of cancer: recent developments. J Transl Med (2004) 1.03
Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib. BMC Cancer (2010) 1.01
Biology and significance of circulating and disseminated tumour cells in colorectal cancer. Langenbecks Arch Surg (2012) 1.01
Hemodynamic parameters in blood vessels in choroidal melanoma xenografts and rat choroid. Invest Ophthalmol Vis Sci (2002) 1.00
Photoswitchable nanoparticles for in vivo cancer chemotherapy. Proc Natl Acad Sci U S A (2013) 0.99
Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. Am J Pathol (2004) 0.97
Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients. Neoplasia (2010) 0.97
Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. Mol Immunol (2008) 0.97
Microfluidic electroporation of tumor and blood cells: observation of nucleus expansion and implications on selective analysis and purging of circulating tumor cells. Integr Biol (Camb) (2010) 0.95
Drug resistance associated with antiangiogenesis therapy. Semin Cancer Biol (2009) 0.95
Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. J Virol (2002) 0.92
Overexpression of carcinoma and embryonic cytotrophoblast cell-specific Mig-7 induces invasion and vessel-like structure formation. Am J Pathol (2007) 0.92
Tumor cell plasticity and angiogenesis in human melanomas. PLoS One (2012) 0.92
GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer (2009) 0.92
Prognostic and predictive biomarkers: tools in personalized oncology. Mol Diagn Ther (2014) 0.92
MR molecular imaging of tumor vasculature and vascular targets. Adv Genet (2010) 0.91
Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma. J Cell Biochem (2008) 0.91
Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape. Nat Rev Clin Oncol (2016) 0.91
Application of GFP imaging in cancer. Lab Invest (2015) 0.90
Origin of the vasculature supporting growth of primary patient tumor xenografts. J Transl Med (2013) 0.90
Non-uniform plasma leakage affects local hematocrit and blood flow: implications for inflammation and tumor perfusion. Ann Biomed Eng (2007) 0.89
Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer? J Transl Med (2013) 0.88
Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors. Am J Transl Res (2015) 0.87
Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model. Mol Cancer (2006) 0.87
Expected clinical applications of circulating tumor cells in breast cancer. World J Clin Oncol (2011) 0.87
Vascular channels formed by subpopulations of PECAM1+ melanoma cells. Nat Commun (2014) 0.85
PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin. Oncogenesis (2012) 0.85
A mathematical model of tumour self-seeding reveals secondary metastatic deposits as drivers of primary tumour growth. J R Soc Interface (2013) 0.84
Macrophages and angiogenesis in rheumatic diseases. Vasc Cell (2013) 0.84
Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget (2015) 0.83
Bifunctional phage-based pretargeted imaging of human prostate carcinoma. Nucl Med Biol (2009) 0.83
Morphological analysis of tumor cell/endothelial cell interactions under shear flow. J Biomech (2006) 0.83
Evolving homeostatic tissue using genetic algorithms. Prog Biophys Mol Biol (2011) 0.83
Antibody-directed effector cell therapy of tumors: analysis and optimization using a physiologically based pharmacokinetic model. Neoplasia (2002) 0.81
Can mosaic tumor vessels facilitate molecular diagnosis of cancer? Proc Natl Acad Sci U S A (2001) 0.81
Prognostic relevance of minimal residual disease in colorectal cancer. World J Gastroenterol (2014) 0.81
Tumor and endothelial cell hybrids participate in glioblastoma vasculature. Biomed Res Int (2014) 0.81
Tumor angiogenesis-characteristics of tumor endothelial cells. Int J Clin Oncol (2016) 0.81
Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection. World J Gastroenterol (2012) 0.81
Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy. Curr Angiogenes (2012) 0.80
A cell transportation solution that preserves live circulating tumor cells in patient blood samples. BMC Cancer (2016) 0.80
Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}/JAK/STAT1 signaling is critical for the expression of PTN in macrophages. FASEB J (2009) 0.80
Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapy. Cancer Cell Int (2006) 0.80
Immunoexpression of endoglin in brain metastasis secondary to malignant melanoma: evaluation of angiogenesis and comparison with brain metastasis secondary to breast and lung carcinomas. Clin Exp Metastasis (2007) 0.80
Immobilized surfactant-nanotube complexes support selectin-mediated capture of viable circulating tumor cells in the absence of capture antibodies. J Biomed Mater Res A (2015) 0.80
Biological behaviors and proteomics analysis of hybrid cell line EAhy926 and its parent cell line A549. J Exp Clin Cancer Res (2009) 0.80
Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model. J Cancer Res Clin Oncol (2012) 0.79
Antiangiogenic therapy in human gastrointestinal malignancies. Gut (2006) 0.79
A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells. Oncotarget (2014) 0.79
Synthesis and characterization of polystyrene embolization particles doped with tantalum oxide nanoparticles for X-ray contrast. J Mater Sci Mater Med (2015) 0.79
Circulating tumor cell isolation: the assets of filtration methods with polycarbonate track-etched filters. Chin J Cancer Res (2015) 0.78
Intraoperative intravital microscopy permits the study of human tumour vessels. Nat Commun (2016) 0.78
Mig-7 linked to vasculogenic mimicry. Am J Pathol (2007) 0.78
Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow. Biomaterials (2015) 0.78
Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -. Cancer Res Treat (2006) 0.78
Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium? Graefes Arch Clin Exp Ophthalmol (2006) 0.78
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells. Clin Exp Metastasis (2016) 0.77
Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process. Clin Exp Metastasis (2015) 0.77
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res (2000) 6.42
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Determinants of tumor blood flow: a review. Cancer Res (1988) 5.56
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest (2000) 5.52
Fractals and cancer. Cancer Res (2000) 4.05
Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res (1974) 3.96
Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res (1992) 3.77
During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med (1996) 3.18
Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci U S A (1998) 2.92
Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res (1997) 2.61
Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (1997) 2.59
Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res (1975) 2.49
Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest (2000) 2.01
Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol (1996) 1.97
The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest (1966) 1.94
Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res (1999) 1.67
Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name? Am J Pathol (1999) 1.54
Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science (1993) 1.47
Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. Proc Natl Acad Sci U S A (1988) 1.41
Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol (2000) 1.40
Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin Cancer Res (1997) 1.38
Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. J Natl Cancer Inst (1991) 1.20
The fine structure of tumor blood vessels. I. Participation of non-endothelial cells in tumor angiogenesis. Int J Microcirc Clin Exp (1985) 1.14
Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity. Br J Cancer (1999) 1.09
Interaction of activated natural killer cells with normal and tumor vessels in cranial windows in mice. Microvasc Res (1995) 1.08
Tissue-isolated human tumor xenografts in athymic nude mice. Microvasc Res (1994) 1.03
New type of blood vessel found in tumors. Science (1999) 0.91
Scanning electron microscopy of frozen-cracked, dry-cracked, and enzyme-digested retinal tissue of a monkey (Cercopithecus aethiops) and of man. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1980) 0.85
Assignment of laminin heavy chains using the lectin Ricinus communis agglutinin-1. Biochem J (1993) 0.83
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr Perinat Epidemiol (2001) 14.31
Implementing findings of research. BMJ (1994) 12.85
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (1998) 11.61
Is the two week rule for cancer referrals working? BMJ (2001) 7.90
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Restriction endonucleases for pulsed field mapping of bacterial genomes. Nucleic Acids Res (1987) 7.03
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science (1999) 6.96
Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med (1997) 6.86
It's not 'just deprivation': why do equally deprived UK cities experience different health outcomes? Public Health (2010) 6.65
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (1997) 6.37
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res (1995) 6.21
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Transport of molecules in the tumor interstitium: a review. Cancer Res (1987) 5.74
Qualitative research methods in general practice and primary care. Fam Pract (1995) 5.72
Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med (2000) 5.58
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med (2001) 5.54
Assessment of clinical competence. Lancet (2001) 5.21
Tumor induction of VEGF promoter activity in stromal cells. Cell (1998) 5.20
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A (1996) 5.04
Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res (2000) 4.89
Does continuing medical education in general practice make a difference? BMJ (1999) 4.40
Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci (1999) 4.27
Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25
Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer (2007) 4.22
Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial. Ann Intern Med (1994) 4.09
Fractals and cancer. Cancer Res (2000) 4.05
New ages for the last Australian megafauna: continent-wide extinction about 46,000 years ago. Science (2001) 3.91
Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A (2001) 3.88
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res (1994) 3.84
Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res (1992) 3.77
Increased vascularization in mice overexpressing angiopoietin-1. Science (1998) 3.67
Consent and confidentiality in teaching in general practice: survey of patients' views on presence of students. BMJ (1997) 3.64
p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J (1991) 3.55
Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res (1994) 3.54
Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract (1989) 3.53
Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A (1999) 3.49
Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev (2001) 3.39
Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res (2000) 3.39
A study of general practitioners' reasons for changing their prescribing behaviour. BMJ (1996) 3.36
Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. Biophys J (1999) 3.26
Why do qualitative research? BMJ (1995) 3.23
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol (1998) 3.18
During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med (1996) 3.18
Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res (1990) 3.18
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res (1992) 3.09
Lead-contaminated soil abatement and urban children's blood lead levels. JAMA (1993) 3.06
Microvascular permeability of normal and neoplastic tissues. Microvasc Res (1986) 3.04
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J (2001) 3.00
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. Proc Natl Acad Sci U S A (2001) 2.96
Recognition of faux pas by normally developing children and children with Asperger syndrome or high-functioning autism. J Autism Dev Disord (1999) 2.90
Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc Res (1989) 2.82
Mental health care training priorities in general practice. Br J Gen Pract (1997) 2.79
Why do early-emerging tree seedlings have survival advantages?: a test using Acer rubrum (Aceraceae). Am J Bot (1997) 2.77
Solid stress inhibits the growth of multicellular tumor spheroids. Nat Biotechnol (1997) 2.66
Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res (2000) 2.64
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation (1991) 2.62
Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci U S A (1989) 2.61
Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol (2008) 2.61
General practitioners with special clinical interests. Clin Med (2001) 2.61
Evaluation of filter paper blood lead methods: results of a pilot proficiency testing program. Clin Chem (1999) 2.58
LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res (2001) 2.48
Prescribing at the interface between hospitals and general practitioners. BMJ (1992) 2.47
Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol (2001) 2.46
Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res (1991) 2.45
Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J Virol (1998) 2.41
Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media. Biophys J (1993) 2.36
Needle stick injuries among health care workers in a tertiary care hospital of India. Indian J Med Res (2010) 2.32
Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial. Diabetes Obes Metab (2013) 2.31
The early detection of colorectal cancer in primary care. Br J Gen Pract (1999) 2.26
Hindered diffusion in agarose gels: test of effective medium model. Biophys J (1996) 2.24
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Time trend analysis and variations in prescribing lipid lowering drugs in general practice. BMJ (1998) 2.21
Selection of the T cell repertoire. Annu Rev Immunol (1999) 2.21
Open access endoscopy. Br Med J (Clin Res Ed) (1985) 2.18
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet A (2003) 2.15
Global status of tospovirus epidemics in diverse cropping systems: successes achieved and challenges ahead. Virus Res (2009) 2.14
Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy. Arch Gen Psychiatry (1993) 2.12
Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis (2008) 2.12
Rectal bleeding: prevalence and consultation behaviour. BMJ (1995) 2.11
Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res (2001) 2.11
Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res (1999) 2.10
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant (2008) 2.10
Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study. Gut (1997) 2.09
Assessment of the performance of five intensive care scoring models within a large Scottish database. Crit Care Med (2000) 2.08
The impact of new technology on general practice. J R Coll Gen Pract (1986) 2.08
Hypercholesterolaemia: not all cases warrant treatment. BMJ (1993) 2.06
Extravascular diffusion in normal and neoplastic tissues. Cancer Res (1984) 2.04
Patients' attitudes to chaperones. J R Coll Gen Pract (1985) 2.01
Experimental atherosclerosis in rhesus monkeys. II. Cellular elements of proliferative lesions and possible role of cytoplasmic degeneration in pathogenesis as studied by electron microscopy. Exp Mol Pathol (1967) 2.00